Literature DB >> 14505569

AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding.

Bettina Strack1, Arianna Calistri, Stewart Craig, Elena Popova, Heinrich G Göttlinger.   

Abstract

HIV-1 and other retroviruses exit infected cells by budding from the plasma membrane, a process requiring membrane fission. The primary late assembly (L) domain in the p6 region of HIV-1 Gag mediates the detachment of the virion by recruiting host Tsg101, a component of the class E vacuolar protein sorting (Vps) machinery. We now show that HIV Gag p6 contains a second region involved in L domain function that binds AIP1, a homolog of the yeast class E Vps protein Bro1. Further, AIP1 interacts with Tsg101 and homologs of a subunit of the yeast class E Vps protein complex ESCRT-III. AIP1 also binds to the L domain in EIAV p9, and this binding correlates perfectly with L domain function. These observations identify AIP1 as a component of the viral budding machinery, which serves to link a distinct region in the L domain of HIV-1 p6 and EIAV p9 to ESCRT-III.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505569     DOI: 10.1016/s0092-8674(03)00653-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  422 in total

1.  Decoding the intrinsic mechanism that prohibits ALIX interaction with ESCRT and viral proteins.

Authors:  Xi Zhou; Jiali Si; Joe Corvera; Gary E Gallick; Jian Kuang
Journal:  Biochem J       Date:  2010-12-15       Impact factor: 3.857

Review 2.  Proline-rich regions and motifs in trafficking: from ESCRT interaction to viral exploitation.

Authors:  Xuefeng Ren; James H Hurley
Journal:  Traffic       Date:  2011-05-13       Impact factor: 6.215

3.  CC2D1A is a regulator of ESCRT-III CHMP4B.

Authors:  Nicolas Martinelli; Bettina Hartlieb; Yoshiko Usami; Charles Sabin; Aurelien Dordor; Nolwenn Miguet; Sergiy V Avilov; Euripedes A Ribeiro; Heinrich Göttlinger; Winfried Weissenhorn
Journal:  J Mol Biol       Date:  2012-03-08       Impact factor: 5.469

4.  Interaction of Moloney murine leukemia virus matrix protein with IQGAP.

Authors:  Juliana Leung; Andrew Yueh; Frank S K Appah; Bing Yuan; Kenia de los Santos; Stephen P Goff
Journal:  EMBO J       Date:  2006-04-20       Impact factor: 11.598

Review 5.  Cargo- and compartment-selective endocytic scaffold proteins.

Authors:  Iwona Szymkiewicz; Oleg Shupliakov; Ivan Dikic
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

6.  Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding.

Authors:  Ido Amit; Liat Yakir; Menachem Katz; Yaara Zwang; Mina D Marmor; Ami Citri; Keren Shtiegman; Iris Alroy; Shmuel Tuvia; Yuval Reiss; Eli Roubini; Maya Cohen; Ron Wides; Eran Bacharach; Ullrich Schubert; Yosef Yarden
Journal:  Genes Dev       Date:  2004-07-15       Impact factor: 11.361

7.  A novel requirement for C. elegans Alix/ALX-1 in RME-1-mediated membrane transport.

Authors:  Anbing Shi; Saumya Pant; Zita Balklava; Carlos Chih-Hsiung Chen; Vanesa Figueroa; Barth D Grant
Journal:  Curr Biol       Date:  2007-11-08       Impact factor: 10.834

8.  Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity.

Authors:  Christelle Brégnard; Alessia Zamborlini; Marjorie Leduc; Philippe Chafey; Luc Camoin; Ali Saïb; Serge Benichou; Olivier Danos; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

9.  Host factors that affect Ty3 retrotransposition in Saccharomyces cerevisiae.

Authors:  Michael Aye; Becky Irwin; Nadejda Beliakova-Bethell; Eric Chen; Jennifer Garrus; Suzanne Sandmeyer
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

10.  Dual role for motif 1 residues of human lysyl-tRNA synthetase in dimerization and packaging into HIV-1.

Authors:  Varun Dewan; Min Wei; Lawrence Kleiman; Karin Musier-Forsyth
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.